<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00137631</url>
  </required_header>
  <id_info>
    <org_study_id>CDC-NCHSTP-CCU224517</org_study_id>
    <secondary_id>U65/CCU224517-01</secondary_id>
    <nct_id>NCT00137631</nct_id>
  </id_info>
  <brief_title>Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM</brief_title>
  <acronym>3MV</acronym>
  <official_title>Evaluation of Many Men, Many Voices, A Group Intervention for STD/HIV Prevention for Black Men Who Have Sex With Men (MSM) in the New York Metropolitan Area by People of Color in Crisis, Brooklyn, NY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centers for Disease Control and Prevention</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this program evaluation is to determine whether the &quot;Many Men, Many Voices&quot;
      HIV/STD prevention intervention is effective in reducing HIV sex risk behaviors and
      increasing HIV testing among African-American men who have sex with men (MSM), who may or may
      not self-identify as gay. The intent of this program is to support the evaluation of an
      existing intervention and provide feedback to the implementing organization for improved
      program effectiveness, not to conduct research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Black men who have sex with men (MSM) in the United States experience disproportionately high
      rates of HIV and other sexually transmitted infections (STIs); however, the number of
      evidence-based interventions for Black MSM is limited. This study evaluated the efficacy of
      Many Men, Many Voices (3MV), a small-group HIV/STI prevention intervention developed by Black
      MSM-serving community-based organizations and a university-based HIV/STI prevention and
      training program. The study sample included 338 Black MSM of HIV-negative or unknown HIV
      serostatus residing in New York city. Participants were randomly assigned to the 3MV
      intervention condition (n = 164) or wait-list comparison condition (n = 174). Relative to
      comparison participants, 3MV participants reported significantly greater reductions in any
      unprotected anal intercourse with casual male partners; a trend for consistent condom use
      during receptive anal intercourse with casual male partners; and significantly greater
      reductions in the number of male sex partners and greater increases in HIV testing. This
      study is the first randomized trial to demonstrate the efficacy of an HIV/STI prevention
      intervention for Black MSM.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Any Unprotected Anal Intercourse (UAI) With Casual Partners</measure>
    <time_frame>6 months</time_frame>
    <description>Sexual activities with casual male partners in past 3 months (i.e., any unprotected insertive or receptive anal sex)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting HIV Testing Behavior</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Sexually Transmitted Disease (STD) Testing Behavior</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Episodes of Insertive Unprotected Anal Intercourse (UAI) With Casual Partners</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Episodes of Receptive Unprotected Anal Intercourse (UAI) With Casual Partners</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">341</enrollment>
  <condition>HIV Infections</condition>
  <condition>Sexually Transmitted Diseases</condition>
  <arm_group>
    <arm_group_label>Many Men, Many Voices (3MV) Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait list comparison</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receive intervention after 6-month delay (wait list control group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Many Men, Many Voices (3MV)</intervention_name>
    <description>Small-group, 6-session HIV prevention intervention for Black MSM.</description>
    <arm_group_label>Many Men, Many Voices (3MV) Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Black men who have sex with other men (i.e., self-identify as gay or bisexual or same
             gender-loving, or sexually active with other men and do not identify as gay or
             bisexual, or have sexual or emotional attraction to other men)

          -  18 years of age or older

          -  Self-report their HIV serostatus as negative or unknown

          -  Willing to attend an intervention retreat (without their primary partner)

          -  Willing to discuss male-to-male sex

          -  Resident of the New York Metropolitan area and plan to reside in that area for at
             least 6 months

          -  Not previously participated in a Many Men, Many Voices intervention program

        Exclusion Criteria:

          -  Individuals indicating an HIV positive serostatus

          -  Under 17 years of age

          -  Individuals not meeting the inclusion criteria specified above
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas M Painter, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey H Herbst, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>People of Color in Crisis, Inc.</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11217</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Coury-Doniger P, Wilton L, Herbst JH, Painter TM. HIV prevention interventions for black MSM. Am J Public Health. 2010 Feb;100(2):198. doi: 10.2105/AJPH.2009.182485. Epub 2009 Dec 17.</citation>
    <PMID>20019294</PMID>
  </reference>
  <results_reference>
    <citation>Wilton L, Herbst JH, Coury-Doniger P, Painter TM, English G, Alvarez ME, Scahill M, Roberson MA, Lucas B, Johnson WD, Carey JW. Efficacy of an HIV/STI prevention intervention for black men who have sex with men: findings from the Many Men, Many Voices (3MV) project. AIDS Behav. 2009 Jun;13(3):532-44. doi: 10.1007/s10461-009-9529-y. Epub 2009 Mar 9.</citation>
    <PMID>19267264</PMID>
  </results_reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2005</study_first_submitted>
  <study_first_submitted_qc>August 26, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2005</study_first_posted>
  <results_first_submitted>March 10, 2010</results_first_submitted>
  <results_first_submitted_qc>April 27, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 14, 2010</results_first_posted>
  <last_update_submitted>June 23, 2010</last_update_submitted>
  <last_update_submitted_qc>June 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Executive Director</name_title>
    <organization>People of Color in Crisis, Inc.</organization>
  </responsible_party>
  <keyword>Adult</keyword>
  <keyword>HIV Infections / pc [Prevention &amp; Control]</keyword>
  <keyword>Homosexuality, Male</keyword>
  <keyword>Humans</keyword>
  <keyword>Male</keyword>
  <keyword>Risk-Taking</keyword>
  <keyword>Safe Sex</keyword>
  <keyword>Sexual Behavior</keyword>
  <keyword>HIV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Sexually Transmitted Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From August 2005 through November 2006, People of Color in Crisis Inc. recruited potential participants from venues throughout New York City.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Many Men, Many Voices (3MV) Intervention</title>
          <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
        </group>
        <group group_id="P2">
          <title>Wait List Comparison</title>
          <description>Receive intervention after 6-month delay (wait list control group)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="164"/>
                <participants group_id="P2" count="174"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Complete 3-month Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed 6-month Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="127">7 participants who were lost to follow-up at 3-months were retained at 6-months</participants>
                <participants group_id="P2" count="133">8 participants who were lost to follow-up at 3-months were retained at 6-months</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="133"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Many Men, Many Voices (3MV) Intervention</title>
          <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
        </group>
        <group group_id="B2">
          <title>Wait List Comparison</title>
          <description>Receive intervention after 6-month delay (wait list control group)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="164"/>
            <count group_id="B2" value="174"/>
            <count group_id="B3" value="338"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.5" spread="9.1"/>
                    <measurement group_id="B2" value="29.7" spread="9.5"/>
                    <measurement group_id="B3" value="29.6" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="174"/>
                    <measurement group_id="B3" value="338.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="174"/>
                    <measurement group_id="B3" value="338.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Any Unprotected Anal Intercourse (UAI) With Casual Partners</title>
        <description>Sexual activities with casual male partners in past 3 months (i.e., any unprotected insertive or receptive anal sex)</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Many Men, Many Voices (3MV) Intervention</title>
            <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
          </group>
          <group group_id="O2">
            <title>Wait List Comparison</title>
            <description>Receive intervention after 6-month delay (wait list control group)</description>
          </group>
        </group_list>
        <measure>
          <title>Any Unprotected Anal Intercourse (UAI) With Casual Partners</title>
          <description>Sexual activities with casual male partners in past 3 months (i.e., any unprotected insertive or receptive anal sex)</description>
          <units>Number of episodes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="5.6"/>
                    <measurement group_id="O2" value="6.2" spread="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>negative binomial regression</method>
            <param_type>Rate Ratio</param_type>
            <param_value>0.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.33</ci_lower_limit>
            <ci_upper_limit>1.01</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting HIV Testing Behavior</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Many Men, Many Voices (3MV) Intervention</title>
            <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
          </group>
          <group group_id="O2">
            <title>Wait List Comparison</title>
            <description>Receive intervention after 6-month delay (wait list control group)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting HIV Testing Behavior</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                    <measurement group_id="O2" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>generalized estimating equations</method>
            <method_desc>Tests intervention efficacy over all study periods (baseline, 3-months, and 6-months)</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.05</ci_lower_limit>
            <ci_upper_limit>1.68</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Sexually Transmitted Disease (STD) Testing Behavior</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Many Men, Many Voices (3MV) Intervention</title>
            <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
          </group>
          <group group_id="O2">
            <title>Wait List Comparison</title>
            <description>Receive intervention after 6-month delay (wait list control group)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Sexually Transmitted Disease (STD) Testing Behavior</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.69</ci_lower_limit>
            <ci_upper_limit>1.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Episodes of Insertive Unprotected Anal Intercourse (UAI) With Casual Partners</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Many Men, Many Voices (3MV) Intervention</title>
            <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
          </group>
          <group group_id="O2">
            <title>Wait List Comparison</title>
            <description>Receive intervention after 6-month delay (wait list control group)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Episodes of Insertive Unprotected Anal Intercourse (UAI) With Casual Partners</title>
          <units>number of episodes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="3.4"/>
                    <measurement group_id="O2" value="4.5" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>generalized estimating equations</method>
            <method_desc>Tests intervention efficacy over all study periods (baseline, 3-months, and 6-months)</method_desc>
            <param_type>Rate Ratio</param_type>
            <param_value>0.49</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.28</ci_lower_limit>
            <ci_upper_limit>0.87</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Episodes of Receptive Unprotected Anal Intercourse (UAI) With Casual Partners</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Many Men, Many Voices (3MV) Intervention</title>
            <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
          </group>
          <group group_id="O2">
            <title>Wait List Comparison</title>
            <description>Receive intervention after 6-month delay (wait list control group)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Episodes of Receptive Unprotected Anal Intercourse (UAI) With Casual Partners</title>
          <units>number of episodes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="3.3"/>
                    <measurement group_id="O2" value="1.7" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>generalized estimating equations</method>
            <method_desc>Tests intervention efficacy over all study periods (baseline, 3-months, and 6-months)</method_desc>
            <param_type>Rate Ratio</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Many Men, Many Voices (3MV) Intervention</title>
          <description>Receive 6-session intervention immediately after baseline assessment and randomization</description>
        </group>
        <group group_id="E2">
          <title>Wait List Comparison</title>
          <description>Receive intervention after 6-month delay (wait list control group)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="164"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="174"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="164"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="174"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Leo Wilton, PhD</name_or_title>
      <organization>Department of Human Development, State University of New York at Binghamton</organization>
      <phone>607-777-9215</phone>
      <email>lwilton@binghamton.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

